TB-500 2 sizes RESEARCH USE ONLY BLACK BOX BIOTECHNOLOGY · BT5

TB-500

Also known as: Thymosin β4 acetate · Thymosin beta-4 fragment · Tβ4
Recovery & Repair In stock Box of 10 vials 3 references

Thymosin β4-derived peptide studied in wound repair, cell migration and inflammation resolution.

Available sizes

SKUPer vialPack
BT5 5 mg 10 vials / box
BT10 10 mg 10 vials / box

Order TB-500

Pricing is quoted directly and is competitive at every tier — message us with the SKUs you want and quantities for a quote.

Quote on Telegram Quote on Signal

Replies within 36 hours. Cryptocurrency (preferred) or card / money-app with a processing fee. COA for this batch available on request.

TB-500 is the research designation for synthetic thymosin β4 (or its active fragment, supplied here as the acetate salt). Thymosin β4 is a 43-residue actin-sequestering protein present in almost all cells; its actin-binding motif (LKKTETQ, residues 17–23) is responsible for promoting cell migration and wound repair 2.

Reviews of the basic and clinical literature describe thymosin β4 accelerating dermal, corneal and cardiac repair in animal models and in early clinical trials 1. More recent work shows it limits inflammation by promoting autophagy 3.

At a glance

  • Actin-binding, pro-migratory repair peptide
  • Clinical-stage in dermal and ophthalmic wound healing
  • 5 mg and 10 mg vials; also blended with BPC-157
Research use only. All products are sold strictly for laboratory research and development purposes. They are not intended for human or veterinary use, diagnosis, treatment, cure or prevention of any disease. Not for human consumption. Summaries above describe published findings in laboratory and clinical research models and do not constitute claims about this product.
Form
Lyophilized powder
Purity
HPLC-verified — Certificate of Analysis available on request
Pack size
Box of 10 vials
Storage
Lyophilized: −20 °C, protected from light (2–8 °C short-term). Reconstituted: 2–8 °C.
Formula
C212H350N56O78S
Mol. weight
4963.4 g/mol
CAS No.
77591-33-4

Sequence, formula and CAS data are provided for identification. Batch-specific purity, mass-spec and HPLC data are on the Certificate of Analysis — ask for it with your order.

  1. Goldstein AL, Kleinman HK Advances in the basic and clinical applications of thymosin β4. Expert Opin Biol Ther. 2015;15 Suppl 1:S139-45.
  2. Sosne G, Qiu P, Goldstein AL, et al. Biological activities of thymosin beta4 defined by active sites in short peptide sequences. FASEB J. 2010;24(7):2144-51.
  3. Renga G, Oikonomou V, Stincardini C, et al. Thymosin β4 limits inflammation through autophagy. Expert Opin Biol Ther. 2018;18(sup1):171-175.

Citations retrieved from PubMed (NCBI). Links open the publisher record via DOI and the PubMed abstract.

Related

Often ordered together

More in Recovery
Quote on Telegram